A research letter presents results of a study on opioid use among patients in the SEER database who underwent open resection vs VATS for non-small cell lung cancer.
Researchers sought to determine the incidence and demographic factors of patients with cancer whose deaths were attributed to opioid overdose over a 10-year period.
Researchers presented results of a project designed to reduce opioid use while effectively managing pain and anxiety in patients who had undergone surgery for urologic cancer at the 2018 ASCO Quality Care Symposium.
Comprehensive bipartisan package earmarks billions of dollars to fight opioid abuse in the United States
Investigators reviewed 6 opioid analgesics for package information on safe storage and disposal methods.
Researchers examine the possible impact that opioid products marketed by the pharmaceutical industry may have on clinician prescribing rates.
Results of a retrospective review assessing the prevalence of chronic opioid use among patients with oropharynx cancer after surgery was presented at the 2018 American Head & Neck Society Annual Meeting.
Use of an opioid prescription protocol greatly reduced opioid use among patients who underwent gynecologic surgery, according to presentation at the 2018 Society of Gynecologic Oncology Annual Meeting on Women's Cancer.
Researchers compared opioid use between head and neck cancer (HNCA) and lung or colon cancer (LCCA) cohorts.
Compared with placebo, gabapentin administered pre- and postoperatively may reduce the time to postoperative opioid cessation, but was not shown to improve postoperative pain resolution.
Researchers sought to determine the link between opioid use among patients with advanced cancer and health care use such as urgent care, inpatient, and emergency room visits.
Clinicians should use immunoassay screens and urine drug tests to determine compliance with chronic opioid therapy.
A report on current legislation and practice trends regarding opioids and how they are affecting cancer patients' ability to manage their pain.
A randomized study was conducted to determine the efficacy of prophylactic prochlorperazine in reducing opioid-induced nausea and vomiting in patients with cancer receiving opioids for pain management.
Investigators the effectiveness of an intervention to reduce aberrant opioid-related behavior and use of opioids in patients with cancer receiving chronic opioid therapy.
The Rx Awareness campaign uses testimonials to educate the public, increase awareness about opioid abuse risks.
Two CDC reports point to the drug fentanyl as a major contributor to the increase in U.S. opioid-related overdose deaths.
Rates of opioid prescription use is higher among patients with cancer compared with patients who have never had cancer, even after survivorship.
A significant variation in opioid prescribing practices was observed for each of 25 common elective procedures.
U.S. cases of opioid-related hospitalizations rose 75 percent for females versus 55 percent for males over a decade, researchers say
Patient expectations, clinician perception, and institutional objectives create a perfect storm of conflicting interests regarding pain management, especially given the current trend to control opioid use.
Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.
Drug abuse may cause an unusual short-term memory syndrome
This study assessed whether the implementation of a patient educational program would improve patterns in the use, storage, and disposal of opioids among cancer outpatients.
Patient abuse of opioids costs the U.S. economy $78.5 billion a year, including the costs of health care, lost productivity, and treatment programs.
Almost 15 percent of older adults surveyed used high-risk methods for obtaining prescription opioids, according to a recent study.
Despite the infrequency of urine drug test ordering, greater than half of all urine drug tests results were abnormal among outpatients with advanced cancer.
Methadone appears to be superior to fentanyl for the treatment of neuropathic pain in patients with head and neck cancer.
Managing pain with opioids and keeping a close eye on adverse effects is an important part of cancer care. But there is room for improvement in pain management tools, and nurses play a key role in their evolution.
Health experts note that opioids are prescribed too often, possibly because of poor training, and U.S. medical schools are expanding training to address the issue.
Sign Up for Free e-newsletters
- Smoking Ups Risk of Myeloproliferative Neoplasms Overall and by Subtype
- Myelofibrosis: From Diagnosis to Early Intervention
- FDA Approves HPV Vaccine for People Through Age 45
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients
- Tandem Autologous-Allogenic HCT Offers Long-Term Remission in Multiple Myeloma
- Tool Addresses Well-being of Informal Caregivers of Patients With Cancer
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- Navigation at the End of Therapy: A Crucial Transition in Lymphoma Treatment
- Strength and Hope for Women in the Mist of Cancer
- Prospective Study Measures Cognitive, Treatment Effects in Older Breast Cancer Survivors
- Immune Checkpoint Inhibitor Therapy May Affect Thyroid Function
- Hypofractionated Radiotherapy After Conservative Surgery May Increase Low-intermediate Grade Late Fibrosis in Breast Cancer Patients
- Should Increased Breast Density Dictate More Breast Cancer Screenings?
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|